IDEAYA Biosciences (NASDAQ:IDYA) Price Target Raised to $36.00
IDEAYA Biosciences (NASDAQ:IDYA – Free Report) had its price objective boosted by Royal Bank of Canada from $32.00 to $36.00 in a report published on Tuesday morning, Benzinga reports. The brokerage currently has an outperform rating on the stock. Several other equities analysts have also commented on the stock. SVB Leerink assumed coverage on shares […]
More Stories
RFK Jr. Announces American-Made Seafood Label at Midterm Rally in Florida
By Troy Myers Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has announced a new American-made label for...
France on Fire: Who Is Behind the Riots, Who Benefits From the Chaos—and Could a Fallen Republic Put Nuclear Weapons at Risk?
By Stephen Zogopoulos, Founder & Chief Executive Officer, USNN World News France Is Not Simply Protesting. The Republic Is Facing...
US to Tap Petroleum Reserve for 400,000 Barrels in Exchange to Shore Up Louisiana Refinery
By Kimberly Hayek Federal officials authorized the release of up to 400,000 barrels of crude oil from the Strategic Petroleum...
Trump Calls On Data Center Developers to Pay Communities a Dividend
By Chris Summers President Donald Trump has suggested that companies building data centers in the United States should offer local...
Why America Has a Housing Shortage Alongside an Abundance of Empty Homes
By Autumn Spredemann Homes sit empty across the United States while potential owners and renters face affordability challenges and housing...
Riots, Rates, and Risks—The Economic Roots of France’s Unrest
By Andrew Moran Unrest has gripped France as nationwide protests over the rising cost of living have swept across the...